WebbThis makes FKBP51 a unique and attractive therapeutic target to treat PTSD and MDD. In addition, aged wild-type mice may be a useful model for investigating the mechanisms … WebbFKBP51 acts through GSK3β on the downstream targets Tau, β-catenin and T-cell factor/lymphoid enhancing factor (TCF/LEF). Lithium and the antidepressant (AD) …
The Prospect of FKBP51 as a Drug Target Semantic Scholar
Webbcord level. Here, we explored the potential of FKBP51 as a new pharmacological target for the treatment of persistent pain across the sexes. First, we demonstrated that FKBP51 regulates long-term pain states of different aetiologies independently of sex. Deletion of FKBP51 reduced the mechanical hypersensitivity seen in joint inflammatory and … Webb8 mars 2024 · FKBP51 is an important mediator of the st... Depression and posttraumatic stress disorder increase the risk of ... The prospect of FKBP51 as a drug target. ChemMedChem 7, 1351–1359 (2012). Crossref. PubMed. Google Scholar. 36. S. Gong et al., Dynamics and correlation of serum cortisol and corticosterone under different ... in abc ab ac
检索结果-暨南大学图书馆
WebbFKBP 51 has emerged as a promising new drug target for stress‐related disorders that should be amenable to drug discovery and is highly suited for X‐ray co‐crystallography, … Webb1 juni 2024 · During the course of the study scientist found that FKBP51 acts on a pathway independent of mTOR (mammalian Target of Rapamycin), which is associated with rapamycin. Scientists also identified a small molecule, SAFit2, which crossed the blood-brain barrier and promoted autophagy and reduced the toxic disease-causing protein … Webb27 juli 2024 · FKBP51 (FK506-binding protein 51) is a known co-chaperone and regulator of the glucocorticoid receptor (GR), which usually attenuates its activity. FKBP51 is one of the major GR target genes in skin, but its role in clinical effects of glucocorticoids is not known. Here, we used FKBP51 knockout (KO) mice to determine FKBP51’s role in the in aba what are the functions of behavior